Literature DB >> 28281973

ABCB5-ZEB1 Axis Promotes Invasion and Metastasis in Breast Cancer Cells.

Juntao Yao, Xuan Yao, Tao Tian, Xiao Fu, Wenjuan Wang, Suoni Li, Tingting Shi, Aili Suo, Zhiping Ruan, Hui Guo, Kejun Nan, Xiongwei Huo.   

Abstract

ABCB5 belongs to the ATP-binding cassette (ABC) superfamily, which is recognized for playing a role in the failure of chemotherapy. ABCB5 has also been found to be overexpressed at the transcriptional level in a number of cancer subtypes, including breast cancer. However, the exact mechanism ABCB5 uses on cancer cell metastasis is still unclear. In the present study, we demonstrate that ABCB5 expression was increased in metastatic tissues when compared with nonmetastatic tissues. ABCB5 can significantly enhance metastasis and epithelial-mesenchymal transition (EMT), while knockdown of ABCB5 inhibited these processes. Microarray analysis indicated that ZEB1 may function as a downstream factor of ABCB5. Furthermore, the expression of ZEB1 in tissues is positively relevant to ABCB5 in breast cancer. Knocking down ZEB1 inhibits ABCB5 ectopic expression-induced migration and invasion, as well as EMT. Taken together, these results helped to realize the oncogene functions of ABCB5 in breast cancer cells and provided a new direction in treating breast cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28281973     DOI: 10.3727/096504016X14734149559061

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  10 in total

1.  Treating breast cancer metastasis with cabazitaxel-loaded polymeric micelles.

Authors:  Tao Zhong; Bin He; Hai-Qiang Cao; Tao Tan; Hai-Yan Hu; Ya-Ping Li; Zhi-Wen Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-05-01       Impact factor: 6.150

2.  LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.

Authors:  T Boulding; R D McCuaig; A Tan; K Hardy; F Wu; J Dunn; M Kalimutho; C R Sutton; J K Forwood; A G Bert; G J Goodall; L Malik; D Yip; J E Dahlstrom; A Zafar; K K Khanna; S Rao
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

3.  CircFoxo3 Promotes Adriamycin Resistance Through Regulation of miR-199a-5p/ATP Binding Cassette Subfamily C Member 1 Axis in Hepatocellular Carcinoma.

Authors:  Wei Huang; Feizhou Huang; Chao Feng
Journal:  Onco Targets Ther       Date:  2020-06-08       Impact factor: 4.147

4.  MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest.

Authors:  Yang Wang; Nan Wu; Jun Zhang; Huidong Wang; Xiaojuan Men
Journal:  Onco Targets Ther       Date:  2020-05-12       Impact factor: 4.147

5.  Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1.

Authors:  Ruoming Wang; Tengteng Zhang; Zhen Yang; Chunxia Jiang; Jingjing Seng
Journal:  J Cell Mol Med       Date:  2018-07-03       Impact factor: 5.310

6.  MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2.

Authors:  Mei Liu; Can Gong; Renyuan Xu; Yu Chen; Xiaodong Wang
Journal:  Cell Mol Biol Lett       Date:  2019-07-01       Impact factor: 5.787

7.  IS THERE A CLINICAL PATHOLOGICAL CORRELATION OF COLORECTAL ADENOCARCINOMA WITH THE IMMUNOHISTOCHEMICAL EXPRESSION OF OPN AND ABCB5?

Authors:  Diogo Francesco Castoldi; Osvaldo Malafaia; Pedro Helo Dos Santos-Neto; Tatiana Varella Postiglioni; Cecilia Vasconcelos; Fabiola Past Bremer; Leticia Elizabeth Augustin Czeczko; Martin Gasser; Ana Maria Waaga-Gasser; Carmen Australia Paredes Marcondes Ribas
Journal:  Arq Bras Cir Dig       Date:  2021-03-22

8.  Human-derived osteoblast-like cells and pericyte-like cells induce distinct metastatic phenotypes in primary breast cancer cells.

Authors:  Vera Mayo; Annie C Bowles; Laura E Wubker; Ismael Ortiz; Albert M Cordoves; Richard J Cote; Diego Correa; Ashutosh Agarwal
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-19

9.  Mechanisms of Drug Resistance and Use of Nanoparticle Delivery to Overcome Resistance in Breast Cancers.

Authors:  Huseyin Beyaz; Hasan Uludag; Doga Kavaz; Nahit Rizaner
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363.

Authors:  Hai Huang; Jie Chen; Cheng-Ming Ding; Xin Jin; Ze-Ming Jia; Jian Peng
Journal:  J Cell Mol Med       Date:  2018-03-30       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.